26 results on '"Bassani, N"'
Search Results
2. Correlation between the presence of degenerated inclusion-bearing cells in voided urine samples and the occurrence of polyomavirus infection
- Author
-
Ranzi, A. D., primary, Introíni, G. O., additional, Prolla, J. C., additional, Brackmann, R., additional, Bassani, N. C., additional, Pasqualotto, A. C., additional, and Bica, C. G., additional
- Published
- 2016
- Full Text
- View/download PDF
3. Gammaglobulin level and soy-protein intake in early infancy
- Author
-
Zoppi, G., Zamboni, G., Bassani, N., and Vazzoler, G.
- Published
- 1979
- Full Text
- View/download PDF
4. Transcriptional profiling of melanoma sentinel nodes identify patients with poor outcome and reveal an association of CD30(+) T lymphocytes with progression
- Author
-
Vallacchi, V, Vergani, E, Camisaschi, C, Deho, P, Cabras, A, Sensi, M, De Cecco, L, Bassani, N, Ambrogi, F, Carbone, A, Crippa, F, Vergani, B, Frati, P, Arienti, F, Patuzzo, R, Villa, A, Biganzoli, E, Canevari, S, Santinami, M, Castelli, C, Rivoltini, L, Rodolfo, M, VERGANI, BARBARA, VILLA, ANTONELLO, Rodolfo, M., Vallacchi, V, Vergani, E, Camisaschi, C, Deho, P, Cabras, A, Sensi, M, De Cecco, L, Bassani, N, Ambrogi, F, Carbone, A, Crippa, F, Vergani, B, Frati, P, Arienti, F, Patuzzo, R, Villa, A, Biganzoli, E, Canevari, S, Santinami, M, Castelli, C, Rivoltini, L, Rodolfo, M, VERGANI, BARBARA, VILLA, ANTONELLO, and Rodolfo, M.
- Abstract
Sentinel lymph nodes set the stance of the immune system to a localized tumor and are often the first site to be colonized by neoplastic cells that metastasize. To investigate how the presence of neoplastic cells in sentinel lymph nodes may trigger pathways associated with metastatic progression, we analyzed the transcriptional profiles of archival sentinel node biopsy specimens obtained from melanoma patients. Biopsies from positive nodes were selected for comparable tumor infiltration, presence or absence of further regional node metastases, and relapse at 5-year follow-up. Unsupervised analysis of gene expression profiles revealed immune response to be a major gene ontogeny represented. Among genes upregulated in patients with progressing disease, the TNF receptor family member CD30/TNFRSF8 was confirmed in biopsy specimens from an independent group of patients. Immunohistochemical analysis revealed higher numbers of CD30(+) lymphocytes in nodes from progressing patients compared with nonprogressing patients. Phenotypic profiling demonstrated that CD30(+) lymphocytes comprised a broad population of suppressive or exhausted immune cells, such as CD4(+)Foxp3(+) or PD1(+) subpopulations and CD4(-)CD8(-) T cells. CD30(+) T lymphocytes were increased in peripheral blood lymphocytes of melanoma patients at advanced disease stages. Our findings reinforce the concept that sentinel nodes act as pivotal sites for determining progression patterns, revealing that the presence of CD30(+) lymphocytes at those sites associate positively with melanoma progression.
- Published
- 2014
5. Correlation between the presence of degenerated inclusion-bearing cells in voided urine samples and the occurrence of polyomavirus infection.
- Author
-
Ranzi, A. D., Introíni, G. O., Prolla, J. C., Brackmann, R., Bassani, N. C., Pasqualotto, A. C., and Bica, C. G.
- Subjects
URINALYSIS ,POLYOMAVIRUS diseases ,KIDNEY transplantation ,MOLECULAR diagnosis ,CYTOLOGY - Abstract
Objective The purpose of the present, prospective, cohort study was to monitor urine cytology samples from recipients of renal transplants to search for the occurrence of decoy cells and degenerated inclusion-bearing cells with an aim to correlate the existence of these cells with molecular detection of polyomavirus BK (BKV) DNA in urine. Material and methods This study included patients who underwent renal transplantation. Patients had their urine tested quarterly, during the first year post-transplantation, for the presence of decoy cells and degenerated cells, as well as by quantitative determination of BKV load in the urine and plasma. Results Three hundred and sixty-one examinations were performed on 101 patients within 12 months of attendance. Urine cytology results were: 198 (54.9%) negative and 60 (16.6%) positive for the presence of viral cytopathic effects depending on the presence of BKV infection, 72 (19.9%) positive for the manifestation of degenerated cells and 31 (8.6%) unsatisfactory for analysis. There was a subtle tendency towards the presence of degenerated inclusion-bearing cells in cases in which the virus was detected in voided urine. However, the presence of degenerated cells exhibited a tendency to BKV positivity in months 3, 6 and 9 and, exclusively in month 12, this trend was statistically significant. Conclusions There were not enough strong morphological and staining elements to state the origin of the degenerated cells or to describe the nature of the infection (viral or bacterial), given that these cells were undergoing an apoptotic process in post renal transplant patients. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
6. Complementary use of cluster analysis and biplots to discover and validate patterns of gene expression in microarray data.
- Author
-
Bassani, N., Ambrogi, F., Coradini, D., Boracchi, P., and Biganzoli, E.
- Published
- 2010
- Full Text
- View/download PDF
7. Immunocompetence and dietary protein intake in early infancy.
- Author
-
Zoppi, Giuseppe, Gerosa, Franca, Pezzini, Angela, Bassani, Nilo, Rizzotti, Paolo, Bellini, Pierantonio, Todeschini, Gianna, Zamboni, Giorgio, Vazzoler, Gianfranco, Tridente, Giuseppe, Zoppi, G, Gerosa, F, Pezzini, A, Bassani, N, Rizzotti, P, Bellini, P, Todeschini, G, Zamboni, G, Vazzoler, G, and Tridente, G
- Published
- 1982
8. Gammaglobulin level and quantity and quality of dietary protein intake in early infancy
- Author
-
Zoppi, G, Zamboni, Giorgio, Siviero, M, and Bassani, N.
- Published
- 1978
9. Transcriptional Profiling of Melanoma Sentinel Nodes Identify Patients with Poor Outcome and Reveal an Association of CD30+ T Lymphocytes with Progression
- Author
-
Antonello Domenico Cabras, Paola Deho, Chiara Camisaschi, Monica Rodolfo, Barbara Vergani, Federica Crippa, Niccolò Bassani, Antonino Carbone, Roberto Patuzzo, Silvana Canevari, Paola Frati, Flavio Arienti, Mario Santinami, Loris De Cecco, Licia Rivoltini, Viviana Vallacchi, Elia Biganzoli, Federico Ambrogi, Chiara Castelli, Antonello Villa, Marialuisa Sensi, Elisabetta Vergani, Vallacchi, V, Vergani, E, Camisaschi, C, Deho, P, Cabras, A, Sensi, M, De Cecco, L, Bassani, N, Ambrogi, F, Carbone, A, Crippa, F, Vergani, B, Frati, P, Arienti, F, Patuzzo, R, Villa, A, Biganzoli, E, Canevari, S, Santinami, M, Castelli, C, Rivoltini, L, and Rodolfo, M
- Subjects
Cancer Research ,Pathology ,medicine.medical_specialty ,CD30 ,T-Lymphocytes ,Population ,Ki-1 Antigen ,Antigens, CD30 ,Immune system ,Biopsy ,medicine ,Humans ,education ,Melanoma ,education.field_of_study ,medicine.diagnostic_test ,Sentinel Lymph Node Biopsy ,business.industry ,Computational Biology ,FOXP3 ,Sentinel node ,medicine.disease ,Immunohistochemistry ,Treatment Outcome ,T-Lymphocyte ,Oncology ,Disease Progression ,Transcriptome ,business ,CD8 ,Human - Abstract
Sentinel lymph nodes set the stance of the immune system to a localized tumor and are often the first site to be colonized by neoplastic cells that metastasize. To investigate how the presence of neoplastic cells in sentinel lymph nodes may trigger pathways associated with metastatic progression, we analyzed the transcriptional profiles of archival sentinel node biopsy specimens obtained from melanoma patients. Biopsies from positive nodes were selected for comparable tumor infiltration, presence or absence of further regional node metastases, and relapse at 5-year follow-up. Unsupervised analysis of gene expression profiles revealed immune response to be a major gene ontogeny represented. Among genes upregulated in patients with progressing disease, the TNF receptor family member CD30/TNFRSF8 was confirmed in biopsy specimens from an independent group of patients. Immunohistochemical analysis revealed higher numbers of CD30+ lymphocytes in nodes from progressing patients compared with nonprogressing patients. Phenotypic profiling demonstrated that CD30+ lymphocytes comprised a broad population of suppressive or exhausted immune cells, such as CD4+Foxp3+ or PD1+ subpopulations and CD4−CD8− T cells. CD30+ T lymphocytes were increased in peripheral blood lymphocytes of melanoma patients at advanced disease stages. Our findings reinforce the concept that sentinel nodes act as pivotal sites for determining progression patterns, revealing that the presence of CD30+ lymphocytes at those sites associate positively with melanoma progression. Cancer Res; 74(1); 130–40. ©2014 AACR.
- Published
- 2014
10. ATM phosphorylation of CD98HC increases antiporter membrane localization and prevents chronic toxic glutamate accumulation in Ataxia telangiectasia.
- Author
-
Bishop A, Romero JC, Tonapi S, Parihar M, Loranc E, Miller H, Lawrence L, Bassani N, Robledo D, Cao L, Nie J, Kanda K, Stoja A, Garcia N, Gorthi A, Stoveken B, Lane A, Fan T, Cassel T, Zha S, and Musi N
- Abstract
Ataxia telangiectasia (A-T) is a rare genetic disorder characterized by neurological defects, immunodeficiency, cancer predisposition, radiosensitivity, decreased blood vessel integrity, and diabetes. ATM, the protein mutated in A-T, responds to DNA damage and oxidative stress, but its functional relationship to the progressive clinical manifestation of A-T is not understood. CD98HC chaperones cystine/glutamate (x
c - L) antiporters to the cell membrane, and CD98HC phosphorylation by ATM accelerates membrane localization to acutely increase amino acid transport. Loss of ATM impacts tissues reliant on SLC family antiporters relevant to A-T phenotypes, such as endothelial cells (telangiectasia) and pancreatic α-cells (fatty liver and diabetes) with toxic glutamate accumulation. Bypassing the antiporters restores intracellular metabolic balance both in ATM-deficient cells and mouse models. These findings provide new insight into the long-known benefits of N-acetyl cysteine to A-T cells beyond oxidative stress through removing excess glutamate by production of glutathione.+ L) antiporters to the cell membrane, and CD98HC phosphorylation by ATM accelerates membrane localization to acutely increase amino acid transport. Loss of ATM impacts tissues reliant on SLC family antiporters relevant to A-T phenotypes, such as endothelial cells (telangiectasia) and pancreatic α-cells (fatty liver and diabetes) with toxic glutamate accumulation. Bypassing the antiporters restores intracellular metabolic balance both in ATM-deficient cells and mouse models. These findings provide new insight into the long-known benefits of N-acetyl cysteine to A-T cells beyond oxidative stress through removing excess glutamate by production of glutathione., Competing Interests: Declaration of interest The authors declare no competing financial interests.- Published
- 2024
- Full Text
- View/download PDF
11. Thioredoxin reductase-1 levels are associated with NRF2 pathway activation and tumor recurrence in non-small cell lung cancer.
- Author
-
Delgobo M, Gonçalves RM, Delazeri MA, Falchetti M, Zandoná A, Nascimento das Neves R, Almeida K, Fagundes AC, Gelain DP, Fracasso JI, Macêdo GB, Priori L, Bassani N, Bishop AJR, Forcelini CM, Moreira JCF, and Zanotto-Filho A
- Subjects
- Cullin Proteins, Humans, Kelch-Like ECH-Associated Protein 1 genetics, Kelch-Like ECH-Associated Protein 1 metabolism, NF-E2-Related Factor 2 genetics, NF-E2-Related Factor 2 metabolism, Neoplasm Recurrence, Local genetics, Signal Transduction, Carcinoma, Non-Small-Cell Lung drug therapy, Carcinoma, Non-Small-Cell Lung genetics, Lung Neoplasms drug therapy, Lung Neoplasms genetics, Thioredoxin Reductase 1 genetics, Thioredoxin Reductase 1 metabolism
- Abstract
Activating mutations in the KEAP1/NRF2 pathway characterize a subset of non-small cell lung cancer (NSCLC) associated with chemoresistance and poor prognosis. We herein evaluated the relationship between 64 oxidative stress-related genes and overall survival data from 35 lung cancer datasets. Thioredoxin reductase-1 (TXNRD1) stood out as the most significant predictor of poor outcome. In a cohort of NSCLC patients, high TXNRD1 protein levels correlated with shorter disease-free survival and distal metastasis-free survival post-surgery, including a subset of individuals treated with platinum-based adjuvant chemotherapy. Bioinformatics analysis revealed that NSCLC tumors harboring genetic alterations in the NRF2 pathway (KEAP1, NFE2L2 and CUL3 mutations, and NFE2L2 amplification) overexpress TXNRD1, while no association with EGFR, KRAS, TP53 and PIK3CA mutations was found. In addition, nuclear accumulation of NRF2 overlapped with upregulated TXNRD1 protein in NSCLC tumors. Functional cell assays and gene dependency analysis revealed that NRF2, but not TXNRD1, has a pivotal role in KEAP1 mutant cells' survival. KEAP1 mutants overexpress TXNRD1 and are less susceptible to the cytotoxic effects of the TXNRD1 inhibitor auranofin when compared to wild-type cell lines. Inhibition of NRF2 with siRNA or ML-385, and glutathione depletion with buthionine-sulfoximine, sensitized KEAP1 mutant A549 cells to auranofin. NRF2 knockdown and GSH depletion also augmented cisplatin cytotoxicity in A549 cells, whereas auranofin had no effect. In summary, these findings suggest that TXNRD1 is not a key determinant of malignant phenotypes in KEAP1 mutant cells, although this protein can be a surrogate marker of NRF2 pathway activation, predicting tumor recurrence and possibly other aggressive phenotypes associated with NRF2 hyperactivation in NSCLC., (Copyright © 2021 Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
12. Definition of Outcome-Based Prostate-Specific Antigen (PSA) Thresholds for Advanced Prostate Cancer Risk Prediction.
- Author
-
Ferraro S, Bussetti M, Bassani N, Rossi RS, Incarbone GP, Bianchi F, Maggioni M, Runza L, Ceriotti F, and Panteghini M
- Abstract
We defined prostate-specific antigen (PSA) thresholds from a well calibrated risk prediction model for identifying and excluding advanced prostate cancer (PCa). We retrieved 902 biopsied patients with a pre-biopsy PSA determination (Roche assay). A logistic regression model predictive for PCa including the main effects [i.e., PSA, age, histological evidence of glandular inflammation (GI)] was built after testing the accuracy by calibration plots and Hosmer-Lemeshow test for goodness of fit. PSA thresholds were derived by assuming a diagnostic sensitivity of 95% (rule-out) and 80% (rule-in) for overall and advanced/poorly differentiated PCa. In patients without GI, serum PSA concentrations ≤ 4.1 (<65 years old) and ≤3.7 μg/L (≥65 years old) excluded an advanced PCa (defined as Gleason score ≥ 7 at biopsy), with a negative predictive value of 95.1% [95% confidence interval (CI): 83.0-98.7] and 88.8% (CI: 80.2-93.9), respectively, while PSA > 5.7 (<65) and >6.1 μg/L (≥65) should address biopsy referral. In presence of GI, PSA did not provide a valid estimate for risk of advanced cancer because of its higher variability and the low pre-test probability of PCa. The proposed PSA thresholds may support biopsy decision except for patients with asymptomatic prostatitis who cannot be pre-biopsy identified.
- Published
- 2021
- Full Text
- View/download PDF
13. Dolutegravir-based regimens in treatment-naive and treatment-experienced aging populations: analyses of 6 phase III clinical trials.
- Author
-
Spinelli F, Prakash M, Slater J, van der Kolk M, Bassani N, Grove R, Wynne B, van Wyk J, and Clark A
- Subjects
- Aged, Aging, Heterocyclic Compounds, 3-Ring, Humans, Oxazines, Piperazines, Pyridones, HIV Infections drug therapy, HIV-1
- Abstract
Background: Older adults living with HIV (OALWH) are a growing population facing unique challenges to successful antiretroviral therapy. Objective: To assess efficacy and safety profiles of antiretroviral regimens, including those containing dolutegravir, in OALWH. Methods: Combined data from 6 phase III/IIIb trials in treatment-naive (ARIA, FLAMINGO, SINGLE, SPRING-2; N = 2634) and treatment-experienced (DAWNING, SAILING; N = 1339) participants receiving dolutegravir- or non-dolutegravir-based regimens were analyzed by age (<50, ≥50 to <65, and ≥65 years). Baseline data included comorbidities and numbers of concomitant medications. Week 48 efficacy outcomes included virologic response (HIV-1 RNA <50 copies/mL) and CD4+ cell count change from baseline. Safety outcomes included incidence of adverse events (AEs), serious AEs, and AE-related withdrawals. Results: Use of ≥5 concomitant medications was more frequently reported among treatment-naive and treatment-experienced participants aged ≥50 to <65 (30% [90/296] and 25% [57/227], respectively) and ≥65 years (43% [10/23] and 29% [4/14]) than among those aged <50 years (13% [310/2315] and 11% [118/1098]). Comorbidities were more prevalent in the older age groups. For dolutegravir-based regimens, Week 48 rates of virologic response and change in CD4+ cell count were similar across age groups (treatment naive, 80-87% and 234-251 cells/mm
3 ; treatment experienced, 70-100% and 105-156 cells/mm3 , respectively). There were no major differences in safety outcomes in each age group. Conclusions: In these analyses of combined phase III/IIIb trial data, efficacy and safety of dolutegravir-based regimens were generally similar across age groups in treatment-naive or treatment-experienced participants. Polypharmacy and comorbidities were more common among OALWH than those aged <50 years.- Published
- 2021
- Full Text
- View/download PDF
14. The Parkinson's Disease Comprehensive Response (PDCORE): a composite approach integrating three standard outcome measures.
- Author
-
Luz M, Whone A, Bassani N, Wyse RK, Stebbins GT, and Mohr E
- Abstract
There is an increasing need for improved endpoints to assess clinical trial effects in Parkinson's disease. We propose the Parkinson's Disease Comprehensive Response as a novel weighted composite endpoint integrating changes measured in three established Parkinson's outcomes, including: OFF state Movement Disorder Society Unified Parkinson's Disease Rating Scale Motor Examination scores; Motor Experiences of Daily Living scores; and total good-quality ON time per day. The data source for the initial development of the composite described herein was a recent Phase II trial of glial cell line-derived neurotrophic factor. A wide range of clinically derived relative weights was assessed to normalize for differentially scoring base rates with each endpoint component. The Parkinson's disease comprehensive response, in contrast to examining practically defined OFF state Unified Parkinson's Disease Rating Scale Motor Examination scores alone, showed stability over 40 weeks in placebo patients, and all 432 analyses in this permutation exercise yielded significant differences in favour of glial cell line-derived neurotrophic factor. The findings were consistent with results obtained employing three different global statistical test methodologies and with patterns of intra-patient change. Based on our detailed analyses, we conclude it worth prospectively evaluating the clinical utility, validity and regulatory feasibility of using clinically supported final Parkinson's disease comprehensive response formulas (for both the Unified Parkinson's Disease Rating Scale-based and Movement Disorders Society-Unified Parkinson's Disease Rating Scale-based versions) in future disease-modifying Parkinson's trials. Whilst the data source employed in the initial development of this weighted composite score is from a recent Phase II trial of glial cell line-derived neurotrophic factor, we wish to stress that the results are not described to provide post hoc evidence of the efficacy of glial cell line-derived neurotrophic factor but rather are presented to further the debate of how current regulatory approved rating scales may be combined to address some of the recognized limitations of using individual scales in isolation., (© The Author(s) (2020). Published by Oxford University Press on behalf of the Guarantors of Brain.)
- Published
- 2020
- Full Text
- View/download PDF
15. Reconstruction of Ewing Sarcoma Developmental Context from Mass-Scale Transcriptomics Reveals Characteristics of EWSR1-FLI1 Permissibility.
- Author
-
Miller HE, Gorthi A, Bassani N, Lawrence LA, Iskra BS, and Bishop AJR
- Abstract
Ewing sarcoma is an aggressive pediatric cancer of enigmatic cellular origins typically resulting from a single translocation event t (11; 22) (q24; q12). The resulting fusion gene, EWSR1-FLI1 , is toxic or unstable in most primary tissues. Consequently, attempts to model Ewing sarcomagenesis have proven unsuccessful thus far, highlighting the need to identify the cellular features which permit stable EWSR1-FLI1 expression. By re-analyzing publicly available RNA-Sequencing data with manifold learning techniques, we uncovered a group of Ewing-like tissues belonging to a developmental trajectory between pluripotent, neuroectodermal, and mesodermal cell states. Furthermore, we demonstrated that EWSR1-FLI1 expression levels control the activation of these developmental trajectories within Ewing sarcoma cells. Subsequent analysis and experimental validation demonstrated that the capability to resolve R-loops and mitigate replication stress are probable prerequisites for stable EWSR1-FLI1 expression in primary tissues. Taken together, our results demonstrate how EWSR1-FLI1 hijacks developmental gene programs and advances our understanding of Ewing sarcomagenesis.
- Published
- 2020
- Full Text
- View/download PDF
16. Verification of the harmonization of human epididymis protein 4 assays.
- Author
-
Ferraro S, Borille S, Carnevale A, Frusciante E, Bassani N, and Panteghini M
- Subjects
- Female, Humans, Biological Assay methods, Electrochemical Techniques methods, Immunoassay methods, Luminescent Measurements methods, Ovarian Neoplasms diagnosis
- Abstract
Background: Serum human epididymis protein 4 (HE4) has gained relevance as an ovarian cancer (OC) biomarker and new automated methods have replaced the first released manual EIA by tracing results to it. We verified agreement and bias of automated methods vs. EIA as well as possible effects on patients' management., Methods: One hundred and fifteen serum samples were measured by Abbott Architect i2000, Fujirebio Lumipulse G1200, Roche Modular E170, and Fujirebio EIA. Passing-Bablok regression was used to compare automated assays to EIA and agreement between methods was estimated by Lin's concordance correlation coefficient (CCC). The bias vs. EIA was estimated and compared to specifications derived from HE4 biological variation., Results: Median (25th-75th percentiles) HE4 concentrations (pmol/L) were 84.5 (60.1-148.8) for EIA, 82.7 (50.3-153.9) for Abbott, 89.1 (55.2-154.9) for Roche, and 112.2 (67.8-194.2) for Fujirebio. Estimated regressions and agreements (95% confidence interval) were: Abbott=1.01(0.98-1.03) EIA-4.8(-7.5/-2.6), CCC=0.99(0.99-1.00); Roche=0.91(0.89-0.93) EIA+5.7(4.2/8.0), CCC=0.98(0.98-0.99); Fujirebio=1.20(1.17-1.24) EIA+ 2.4(-0.6/4.9), CCC=0.97(0.96-0.98). The average bias vs. EIA resulted within the desirable goal for Abbott [-3.3% (-6.1/-0.5)] and Roche [-0.2% (-3.0/2.5)]. However, while for Abbott the bias was constant and acceptable along the measurement concentration range, Roche bias increased up to -28% for HE4 values >250 pmol/L. Lumipulse showed a markedly positive bias [25.3% (21.8/28.8)]., Conclusions: Abbott and Roche assays exhibited a good comparability in the range of HE4 values around the previously recommended 140 pmol/L cut-off. For patient monitoring, however, the assay used for determining serial HE4 must not be changed as results from different systems in lower and higher concentration ranges can markedly differ.
- Published
- 2016
- Full Text
- View/download PDF
17. Resistance to Antiangiogenic Therapies by Metabolic Symbiosis in Renal Cell Carcinoma PDX Models and Patients.
- Author
-
Jiménez-Valerio G, Martínez-Lozano M, Bassani N, Vidal A, Ochoa-de-Olza M, Suárez C, García-Del-Muro X, Carles J, Viñals F, Graupera M, Indraccolo S, and Casanovas O
- Subjects
- Angiogenesis Inhibitors pharmacology, Animals, Everolimus pharmacology, Everolimus therapeutic use, Humans, Indoles pharmacology, Indoles therapeutic use, Male, Mice, Nude, Phenotype, Pyrroles pharmacology, Pyrroles therapeutic use, Signal Transduction drug effects, Sunitinib, TOR Serine-Threonine Kinases metabolism, Angiogenesis Inhibitors therapeutic use, Carcinoma, Renal Cell drug therapy, Carcinoma, Renal Cell metabolism, Drug Resistance, Neoplasm drug effects, Kidney Neoplasms drug therapy, Kidney Neoplasms metabolism, Xenograft Model Antitumor Assays
- Abstract
Antiangiogenic drugs are used clinically for treatment of renal cell carcinoma (RCC) as a standard first-line treatment. Nevertheless, these agents primarily serve to stabilize disease, and resistance eventually develops concomitant with progression. Here, we implicate metabolic symbiosis between tumor cells distal and proximal to remaining vessels as a mechanism of resistance to antiangiogenic therapies in patient-derived RCC orthoxenograft (PDX) models and in clinical samples. This metabolic patterning is regulated by the mTOR pathway, and its inhibition effectively blocks metabolic symbiosis in PDX models. Clinically, patients treated with antiangiogenics consistently present with histologic signatures of metabolic symbiosis that are exacerbated in resistant tumors. Furthermore, the mTOR pathway is also associated in clinical samples, and its inhibition eliminates symbiotic patterning in patient samples. Overall, these data support a mechanism of resistance to antiangiogenics involving metabolic compartmentalization of tumor cells that can be inhibited by mTOR-targeted drugs., (Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
18. International ring trial for the validation of an event-specific Golden Rice 2 quantitative real-time polymerase chain reaction method.
- Author
-
Jacchia S, Nardini E, Bassani N, Savini C, Shim JH, Trijatmiko K, Kreysa J, and Mazzara M
- Subjects
- Asia, Europe, Oryza classification, Oryza enzymology, Phospholipase D genetics, Plant Proteins genetics, Plants, Genetically Modified classification, Plants, Genetically Modified enzymology, Real-Time Polymerase Chain Reaction standards, Oryza genetics, Plants, Genetically Modified genetics, Real-Time Polymerase Chain Reaction methods
- Abstract
This article describes the international validation of the quantitative real-time polymerase chain reaction (PCR) detection method for Golden Rice 2. The method consists of a taxon-specific assay amplifying a fragment of rice Phospholipase D α2 gene, and an event-specific assay designed on the 3' junction between transgenic insert and plant DNA. We validated the two assays independently, with absolute quantification, and in combination, with relative quantification, on DNA samples prepared in haploid genome equivalents. We assessed trueness, precision, efficiency, and linearity of the two assays, and the results demonstrate that both the assays independently assessed and the entire method fulfill European and international requirements for methods for genetically modified organism (GMO) testing, within the dynamic range tested. The homogeneity of the results of the collaborative trial between Europe and Asia is a good indicator of the robustness of the method.
- Published
- 2015
- Full Text
- View/download PDF
19. Measurement of plasma renin concentration instead of plasma renin activity decreases the positive aldosterone-to-renin ratio tests in treated patients with essential hypertension.
- Author
-
Lonati C, Bassani N, Gritti A, Biganzoli E, and Morganti A
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Antihypertensive Agents therapeutic use, Essential Hypertension, False Positive Reactions, Female, Humans, Hyperaldosteronism blood, Hyperaldosteronism complications, Hyperaldosteronism diagnosis, Hypertension drug therapy, Hypertension etiology, Male, Middle Aged, Posture physiology, Predictive Value of Tests, Reproducibility of Results, Young Adult, Aldosterone blood, Blood Chemical Analysis methods, Hypertension blood, Renin blood
- Abstract
Background: The plasma aldosterone-to-renin ratio (ARR) for the diagnosis of primary aldosteronism is normally calculated with plasma renin activity (PRA) as denominator. However, new direct renin assays that measure plasma renin concentration (PRC) are progressively replacing PRA because these are faster, simpler, and more reproducible., Objective: To assess whether the calculation of ARR with a direct assay (ARRD, ng/dl/mU/l) instead of PRA (ARRP, ng/dl/ng/ml/h) affects the rate of positive tests in patients on liberal antihypertensive treatment., Design and Participants: PRA, PRC, and plasma aldosterone concentration (PAC) were measured in 88 patients with essential hypertension, both in the supine position and after 60 min of active standing while on treatment with a variety of antihypertensive medications. The same measurements were carried out, for comparison, in 10 patients with proven aldosterone-producing adenoma., Setting: Single center, outpatient hypertension clinic in a tertiary care hospital., Results: In patients with essential hypertension, median ARRP was 12 (range 0-71) in the supine position and 13 (range 0-80) after standing. The corresponding values of ARRD were 0.4 (range 0.01-3) and 0.5 (range 0.02-7.8). Between ARRP and ARRD, there was a linear, highly significant relationship both in supine and standing position (r=0.88 and r=0.92, respectively). Using as threshold of normalcy for ARRP a value less than 30, as it is recommended by guidelines, there were 13 (15%) and 18 (20%) false positives, respectively in supine and standing position, whereas with the threshold of 3.7 for ARRD, there were no false positives in recumbent position and four (5%) after standing. Accordingly, the specificity of ARRP was 0.85 and 0.78 and that of ARRD 1 and 0.95. In 10 patients with primary aldosteronism, median supine ARRP was 298 (range 48-1222) and ARRD 34 (range 2.8-244). Among these patients, no false negatives were found with ARRP and just one with ARRD., Conclusion: The rate of positive tests calculating ARR with PRC is lower than with PRA, the lower rate being found in patients studied in the recumbent position and apparently it is not affected by ongoing antihypertensive treatment.
- Published
- 2014
- Full Text
- View/download PDF
20. Transcriptional profiling of melanoma sentinel nodes identify patients with poor outcome and reveal an association of CD30(+) T lymphocytes with progression.
- Author
-
Vallacchi V, Vergani E, Camisaschi C, Deho P, Cabras AD, Sensi M, De Cecco L, Bassani N, Ambrogi F, Carbone A, Crippa F, Vergani B, Frati P, Arienti F, Patuzzo R, Villa A, Biganzoli E, Canevari S, Santinami M, Castelli C, Rivoltini L, and Rodolfo M
- Subjects
- Computational Biology, Disease Progression, Humans, Immunohistochemistry, Melanoma pathology, T-Lymphocytes pathology, Transcriptome, Treatment Outcome, Ki-1 Antigen immunology, Melanoma genetics, Melanoma immunology, Sentinel Lymph Node Biopsy methods, T-Lymphocytes immunology
- Abstract
Sentinel lymph nodes set the stance of the immune system to a localized tumor and are often the first site to be colonized by neoplastic cells that metastasize. To investigate how the presence of neoplastic cells in sentinel lymph nodes may trigger pathways associated with metastatic progression, we analyzed the transcriptional profiles of archival sentinel node biopsy specimens obtained from melanoma patients. Biopsies from positive nodes were selected for comparable tumor infiltration, presence or absence of further regional node metastases, and relapse at 5-year follow-up. Unsupervised analysis of gene expression profiles revealed immune response to be a major gene ontogeny represented. Among genes upregulated in patients with progressing disease, the TNF receptor family member CD30/TNFRSF8 was confirmed in biopsy specimens from an independent group of patients. Immunohistochemical analysis revealed higher numbers of CD30(+) lymphocytes in nodes from progressing patients compared with nonprogressing patients. Phenotypic profiling demonstrated that CD30(+) lymphocytes comprised a broad population of suppressive or exhausted immune cells, such as CD4(+)Foxp3(+) or PD1(+) subpopulations and CD4(-)CD8(-) T cells. CD30(+) T lymphocytes were increased in peripheral blood lymphocytes of melanoma patients at advanced disease stages. Our findings reinforce the concept that sentinel nodes act as pivotal sites for determining progression patterns, revealing that the presence of CD30(+) lymphocytes at those sites associate positively with melanoma progression.
- Published
- 2014
- Full Text
- View/download PDF
21. Impeding macrophage entry into hypoxic tumor areas by Sema3A/Nrp1 signaling blockade inhibits angiogenesis and restores antitumor immunity.
- Author
-
Casazza A, Laoui D, Wenes M, Rizzolio S, Bassani N, Mambretti M, Deschoemaeker S, Van Ginderachter JA, Tamagnone L, and Mazzone M
- Subjects
- Animals, Cell Hypoxia, Macrophages drug effects, Mice, Mice, Knockout, Neoplasms, Experimental immunology, Neoplasms, Experimental pathology, Neuropilin-1 antagonists & inhibitors, Neuropilin-1 genetics, Semaphorin-3A antagonists & inhibitors, Macrophages physiology, Neoplasms, Experimental blood supply, Neovascularization, Pathologic prevention & control, Neuropilin-1 physiology, Semaphorin-3A physiology, Signal Transduction physiology
- Abstract
Recruitment of tumor-associated macrophages (TAMs) into avascular areas sustains tumor progression; however, the underlying guidance mechanisms are unknown. Here, we report that hypoxia-induced Semaphorin 3A (Sema3A) acts as an attractant for TAMs by triggering vascular endothelial growth factor receptor 1 phosphorylation through the associated holoreceptor, composed of Neuropilin-1 (Nrp1) and PlexinA1/PlexinA4. Importantly, whereas Nrp1 levels are downregulated in the hypoxic environment, Sema3A continues to regulate TAMs in an Nrp1-independent manner by eliciting PlexinA1/PlexinA4-mediated stop signals, which retain them inside the hypoxic niche. Consistently, gene deletion of Nrp1 in macrophages favors TAMs' entrapment in normoxic tumor regions, which abates their pro-angiogenic and immunosuppressive functions, hence inhibiting tumor growth and metastasis. This study shows that TAMs' heterogeneity depends on their localization, which is tightly controlled by Sema3A/Nrp1 signaling., (Copyright © 2013 Elsevier Inc. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
22. Multi-marker network in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: when and what to measure.
- Author
-
Ferraro S, Ardoino I, Bassani N, Santagostino M, Rossi L, Biganzoli E, Bongo AS, and Panteghini M
- Subjects
- Biomarkers blood, Female, Humans, Male, Myocardial Infarction physiopathology, Principal Component Analysis, Statistics as Topic, Time Factors, Blood Chemical Analysis methods, Electrocardiography, Myocardial Infarction blood, Myocardial Infarction surgery, Percutaneous Coronary Intervention
- Abstract
Background: Data on the correlations between biomarkers to suggest cost-effective multi-marker (MM) panels predictive for ST-elevation myocardial infarction (STEMI) patients are lacking. We sought to explore the relationship between cardiac troponin I (cTnI), C-reactive protein (CRP), B-type natriuretic peptide (BNP), and chromogranin A (CgA) accounting for biomarkers' profiles detected within 48h from successful primary percutaneous coronary intervention (PPCI)., Methods: In 73 STEMI patients cTnI, CRP, BNP, and CgA were measured before PPCI and 6, 24, and 48h later. STATIS methods generalizing Principal Component Analysis on three-way data sets were employed to extract information about: 1) similarities between patients, 2) contribution of each time of sampling and 3) correlations between biomarkers' profiles., Results: STEMI patients who underwent successful PPCI emerged to have a homogeneous profile tailored on biomarkers' evaluation within 48h. Their measurements at 24h contributed the most variability and information both to patients' and to biomarkers' profiles. BNP and cTnI were highly correlated and explained the 40.1% of the total variance, whereas CgA resulted independent and explained the 26.3% of the total variance., Conclusions: Markers' measurements at 24h after PPCI contributed most information to the definition of patients' profile. BNP and cTnI resulted interchangeable in a MM panel for reporting about the extent of necrosis., (Copyright © 2012 Elsevier B.V. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
23. Anti-phospholipid induced murine fetal loss: novel protective effect of a peptide targeting the β2 glycoprotein I phospholipid-binding site. Implications for human fetal loss.
- Author
-
de la Torre YM, Pregnolato F, D'Amelio F, Grossi C, Di Simone N, Pasqualini F, Nebuloni M, Chen P, Pierangeli S, Bassani N, Ambrogi F, Borghi MO, Vecchi A, Locati M, and Meroni PL
- Subjects
- Abortion, Spontaneous prevention & control, Animals, Antibodies, Antiphospholipid metabolism, Binding Sites, Female, Gene Expression Profiling, Humans, Mice, Mice, Inbred C57BL, Peptides administration & dosage, Peptides pharmacology, Placenta metabolism, Placenta pathology, Pregnancy, Protein Binding, Trophoblasts drug effects, Trophoblasts metabolism, Abortion, Spontaneous immunology, Antibodies, Antiphospholipid immunology, Peptides metabolism, beta 2-Glycoprotein I chemistry, beta 2-Glycoprotein I metabolism
- Abstract
β2 glycoprotein I (β2GPI)-dependent anti-phospholipid antibodies (aPL) induce thrombosis and affect pregnancy. The CMV-derived synthetic peptide TIFI mimics the PL-binding site of β2GPI and inhibits β2GPI cell-binding in vitro and aPL-mediated thrombosis in vivo. Here we investigated the effect of TIFI on aPL-induced fetal loss in mice. TIFI inhibitory effect on in vitro aPL binding to human trophoblasts was evaluated by indirect immunofluorescence and ELISA. TIFI effect on aPL-induced fetal loss was investigated in pregnant C57BL/6 mice treated with aPL or normal IgG (NHS). Placenta/fetus weight and histology and RNA expression were analyzed. TIFI, but not the control peptide VITT, displayed a dose-dependent inhibition of aPL binding to trophoblasts in vitro. Injection of low doses of aPL at day 0 of pregnancy caused growth retardation and increased fetal loss rate, both significantly reduced by TIFI but not VITT. Consistent with observations in humans, histological analysis showed no evidence of inflammation in this model, as confirmed by the absence of an inflammatory signature in gene expression analysis, which in turn revealed a TIFI-dependent modulation of molecules involved in differentiation and development processes. These findings support the non-inflammatory pathogenic role of aPL and suggest innovative therapeutic approaches to aPL-dependent fetal loss., (Copyright © 2011 Elsevier Ltd. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
24. Epithelial-to-mesenchymal transition, cell polarity and stemness-associated features in malignant pleural mesothelioma.
- Author
-
Casarsa C, Bassani N, Ambrogi F, Zabucchi G, Boracchi P, Biganzoli E, and Coradini D
- Subjects
- Cell Polarity, Epithelial Cells metabolism, Gene Expression Profiling, Humans, Mesoderm metabolism, Epithelial-Mesenchymal Transition physiology, Gene Expression Regulation, Mesothelioma pathology, Pleural Neoplasms pathology
- Abstract
Epithelial-to-mesenchymal transition (EMT) is the fundamental process by which an epithelial cell loses its epithelial characteristics including cell polarity and acquires mesenchymal and stemness-related features. Therefore, we investigated whether malignant pleural mesothelioma (MPMs) histologies were associated with specific patterns of expression of a selected set of genes related to EMT, cell polarity and stemness features. The association between MPM histologies and genes expression were explored using active and passive Principal Components Analysis-based biplots and PAM analysis that provided evidence that with respect to normal tissues, MPMs histologies were better characterized by specific patterns of expression of genes involved in EMT activation, cell polarity and stemness., (Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
25. [Transitory cryptogenic respiratory disorders of the newborn. Attempted pathogenetic interpretation].
- Author
-
Vazzoler G and Bassani N
- Subjects
- Female, Humans, Infant, Newborn, Male, Obstetric Labor Complications, Pregnancy, Pregnancy Complications, Asphyxia Neonatorum etiology, Pulmonary Edema etiology
- Published
- 1976
26. [Treatment of hyperbilirubinemia in the newborn with orotic acid].
- Author
-
Vazzoler G, Bassani N, and Menin A
- Subjects
- Humans, Infant, Newborn, Jaundice, Neonatal drug therapy, Orotic Acid therapeutic use
- Published
- 1974
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.